Mcf Advisors LLC Merck & Co., Inc. Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 17,180 shares of MRK stock, worth $1.71 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

17,180

Previous 16,896 1.68%

Holding current value

$1.71 Million

Previous $2.09 Million 6.74%

% of portfolio

0.14%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $31,566 - $36,627	284 Added 1.68%	17,180 $1.95 Million
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $36,273 - $38,957	293 Added 1.76%	16,896 $2.09 Million
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $91,384 - $106,483	807 Added 5.11%	16,603 $2.19 Million
Q4 2023 Feb 01, 2024	SELL	$100.18 - $109.02 $16,830 - $18,315	-168 Reduced 1.05%	15,796 $1.72 Million
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $112,627 - $125,077	1,094 Added 7.36%	15,964 $1.64 Million
Q2 2023 Jul 24, 2023	BUY	$108.61 - $118.38 $24,111 - $26,280	222 Added 1.52%	14,870 $1.72 Million
Q1 2023 Apr 18, 2023	BUY	$102.94 - $114.86 $342,378 - $382,024	3,326 Added 29.38%	14,648 $1.56 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $37,249 - $47,758	426 Added 3.91%	11,322 $1.26 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $22,823 - $25,639	270 Added 2.54%	10,896 $942,000
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $28,219 - $31,988	338 Added 3.29%	10,626 $973,000
Q1 2022 May 05, 2022	BUY	$73.51 - $82.4 $756,270 - $847,731	10,288 New	10,288 $844,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $682,250 - $854,607	-9,439 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $45,946 - $50,530	641 Added 7.29%	9,439 $709,000
Q2 2021 Aug 10, 2021	BUY	$70.31 - $77.77 $165,439 - $182,992	2,353 Added 36.51%	8,798 $684,000
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $7,161 - $8,435	-104 Reduced 1.59%	6,445 $497,000
Q4 2020 Feb 09, 2021	SELL	$71.77 - $79.65 $153,587 - $170,451	-2,140 Reduced 24.63%	6,549 $536,000
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $193,561 - $219,402	2,645 Added 43.76%	8,689 $721,000
Q1 2020 Apr 24, 2020	SELL	$63.36 - $87.82 $49,737 - $68,938	-785 Reduced 11.5%	6,044 $465,000
Q4 2019 Feb 07, 2020	BUY	$77.58 - $87.54 $17,377 - $19,608	224 Added 3.39%	6,829 $621,000
Q3 2019 Oct 22, 2019	BUY	$76.08 - $82.93 $836 - $912	11 Added 0.17%	6,605 $556,000
Q1 2019 May 07, 2019	SELL	$69.58 - $79.36 $51,280 - $58,488	-737 Reduced 10.05%	6,594 $548,000
Q4 2018 Jan 25, 2019	BUY	$65.24 - $75.71 $5,480 - $6,359	84 Added 1.16%	7,331 $560,000
Q3 2018 Oct 24, 2018	BUY	$57.69 - $67.84 $403 - $474	7 Added 0.1%	7,247 $514,000
Q2 2018 Jul 20, 2018	SELL	$50.83 - $59.72 $19,061 - $22,395	-375 Reduced 4.92%	7,240 $439,000
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $101 - $118	2 Added 0.03%	7,615 $415,000
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $80,269 - $95,850	-1,555 Reduced 16.96%	7,613 $428,000
Q3 2017 Oct 30, 2017	BUY	$58.67 - $63.13 $537,886 - $578,775	9,168	9,168 $587,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account